Citations

Showing 10 of 108152 citations.

Deformation of cranioplasty titanium mesh in a paediatric patient following head trauma
Sharaf, Basel , Asaad, Malke , Banuelos, Joseph, Meaike, Jesse D. , Meaike, Jesse, Sharaf, Basel A

Mayo Clinic

BMJ Case Reports | June 12, 2019 | Volume: 12 | Issue: 6 | Pages: e230421

10.1136/bcr-2019-230421 | PMID 31189547 Get It

Decompressive craniectomy is a life-saving procedure performed to treat intracranial hypertension caused by a variety of conditions. Subsequent cranioplasty reconstruction is needed for brain protection. Different alloplastic materials with different advantages and disadvantages are available for cranial reconstruction. We present the first case of a deformed titanium cranioplasty mesh in a paediatric patient following head trauma. Children who have undergone cranioplasty reconstruction should be counselled to wear a protective helmet when involved in contact sports or activities that may put their implant at risk of trauma.
A PHASE 3 STUDY OF ACALABRUTINIB PLUS BENDAMUSTINE AND RITUXIMAB IN ELDERLY (AGED ≥65 Years) TREATMENT‐NAIVE PATIENTS WITH MANTLE CELL LYMPHOMA
Wang, M. , Chu, MH, Dreyling, Martin , Fogliatto, Laura Maria , Inwards, David J. , Mayer, Jiřı́ , Spurgeon, Stephen E. , Yin, Ming , Chen, T., Group, on behalf of the ACE‐LY‐308, Belada, David , Cheah, Chan Y. , Flinn, Ian W. , Goy, Andre Henri , Jurczak, Wojciech , Re, F., Robak, Tadeusz , Yoon, Sung‐Soo , Zinzani, Pier Luigi , Yin, M., Kahl, Brad S. , Group, on behalf of the ACE‐LY‐308

Mayo Clinic

Hematological Oncology | June 12, 2019 | Volume: 37 | Issue: S2 | Pages: 554-555

10.1002/hon.2632 Get It

High‐Dose Vitamin B12 in Vasodilatory Shock: A Narrative Review
Patel, Jayshil J. , Venegas‐Borsellino, Carla , Willoughby, Rodney E. , Patel, Jayshil J , Freed, Julie K.

Mayo Clinic

Nutrition in Clinical Practice | June 12, 2019 | Volume: 34 | Issue: 4 | Pages: 514-520

10.1002/ncp.10327 | PMID 31187494 Get It

AbstractVasodilatory shock, as observed in postoperative states and sepsis, is hallmarked by low systemic vascular resistance and low blood pressure compensated by increased cardiac output. Gasotransmitters, such as nitric oxide and hydrogen sulfide, are implicated in the development and perpetuation of vasodilatory shock. Established therapies do not target these physiologic drivers of vasodilation. Due to their nontoxic and pleotropic effects, micronutrients are being used as rescue therapy in postoperative vasoplegia and septic shock. Here, we outline the pathophysiology of vasodilatory shock, describe the rationale for vitamin B12 (hydroxocobalamin) in vasodilatory shock, and identify literature evaluating its use in vasoplegic states.
Micrographic Surgery and Dermatologic Oncology Fellowship Selection Criteria
Arpey, Christopher J.

Mayo Clinic

Dermatologic Surgery | June 12, 2019 | Volume: 45 | Issue: 10 | Pages: 1319-1320

10.1097/dss.0000000000001961 | PMID 31584896 Get It

Gender Disparities in Preoperative Resource Use for Wrist Arthroscopy
Vyas, Krishna S. , Akinhanmi, Margaret, Balls-Berry, Joyce E, Asaad, Malke , Balls‐Berry, Joyce E.

Mayo Clinic

Plastic & Reconstructive Surgery | June 12, 2019 | Volume: 144 | Issue: 3 | Pages: 513e-514e

10.1097/prs.0000000000005967 | PMID 31461057 Get It

Assessing Acceptable Risk in New Surgical Procedures, With Special Reference to Gas Emboli in Transanal Total Mesorectal Surgery
Lanier, William L. , Warner, Mark A.

Mayo Clinic

Diseases of the Colon & Rectum | June 12, 2019 | Volume: 62 | Issue: 7 | Pages: 777-780

10.1097/dcr.0000000000001411 | PMID 31188176 Get It

The MATE survey: men's perceptions and attitudes towards menopause and their role in partners’ menopausal transition
Parish, Sharon J. , Bernick, Brian , Mirkin, Sebastián, Faubion, Stephanie S. , Weinberg, Marc

Mayo Clinic

Menopause | June 12, 2019 | Volume: 26 | Issue: 10 | Pages: 1110-1116

10.1097/gme.0000000000001373 | PMID 31188286 Get It

Abstract Objective: The perceptions and attitudes of menopause shared by men are largely unknown. This analysis characterized men's awareness and their understanding of their partner's menopausal transition. Methods: A 35-question, online survey was used to assess men's perceptions and attitudes toward menopause. Men were recruited from an online research marketplace and were eligible to participate if their female partners (45-64 years old) experienced ≥1 of the following symptoms: hot flashes, night sweats, sleepless nights, difficulty sleeping, low libido, mood swings, pain during sex, or vaginal dryness. Couples either lived together full time, or, if living separately, resided together regularly two or more times a week. Results: Of the 1,356 surveys sent to eligible men, 450 (33%) were completed. Most men were between 50 and 69 years (80%), married and not separated (90%), and lived with their partner full time (97%). Men were aware of the symptoms regularly experienced by their partner, with difficulty sleeping (54%) and lack of energy (49%) being frequently identified; these symptoms were attributed to menopause (26%) and/or aging (22%). Of those who were affected by symptoms (63%), most men reported they negatively impacted them (77%), their partners (70%), and relationships (56%). Men engaged in discussions with their partners regarding menopausal symptoms (72%) and believed they were somewhat/very influential (75%) in their partner's decision to seek treatment or make lifestyle adjustments. Conclusions: Overall, men are aware of their partner's menopausal transition and may influence decisions relating to symptom management. Educational interventions would further benefit men's awareness of menopause and available treatment options. Video Summary: http://links.lww.com/MENO/A424.
Increased Length of Stay Associated With Antibiotic Use in Older Adults With Advanced Cancer Transitioned to Comfort Measures
Datta, Rupak , Zhu, Mojun , Allore, Heather , Quagliarello, Vincent, Juthani‐Mehta, Manisha, Han, Ling

Mayo Clinic

American Journal of Hospice and Palliative Medicine® | June 11, 2019 | Volume: 37 | Issue: 1 | Pages: 27-33

10.1177/1049909119855617 | PMID 31185722 Get It

Background: Antibiotic use may increase hospital length of stay (LOS) among older patients with advanced cancer who are transitioned to comfort measures. Methods: We studied a cohort of patients with advanced cancer aged ≥65 years who were transitioned to comfort measures during admission from July 1, 2014, through November 30, 2016. We evaluated the association between antibiotic exposure and LOS using a Poisson regression model adjusted for age, gender, cancer type, comorbidities, infection, and intensive care unit admission. Results: Among 461 patients with advanced cancer, median age was 74 years (range: 65-99), 49.0% (n = 226) were female, and 20.6% (n = 95) had liquid tumors. Overall, 82.9% (n = 382) received ≥1 antibiotic and 64.6% (n = 298) had ≥1 infection diagnosis during hospitalization. Infection diagnoses commonly included sepsis (35%, n = 161/461), pneumonia (25%, n = 117/461), and urinary tract infection (14%, n = 66/461). Among those receiving antibiotics, the most common choices included vancomycin (79%, n = 300/382), cephalosporins (63%, n = 241/382), and penicillins (45%, n = 172/382). In a multivariable Poisson regression model, LOS was 34% longer (count ratio = 1.34, [95% confidence interval: 1.20-1.51]) among those exposed versus unexposed to antibiotics. Conclusions: Antibiotic use among patients with advanced cancer who are transitioned to comfort measures is associated with longer LOS. These data illustrate the importance of tradeoffs associated with antibiotic use, such as unintended increased LOS, when striving for goal-concordant care near the end of life.
New Innovations in Targeted Muscle Reinnervation
Oh, Christine , Carlsen, Brian T.

Mayo Clinic

JBJS Reviews | June 11, 2019 | Volume: 7 | Issue: 6 | Pages: e3-e3

10.2106/jbjs.rvw.18.00138 | PMID 31188155 Get It

» Targeted muscle reinnervation allows for the creation of additional electromyographic signals for a myoelectrically controlled prosthesis in patients who have undergone an upper-extremity amputation. » Targeted muscle reinnervation shows promise in addressing neuroma pain in both the upper and lower extremities. » Areas of further research include targeted sensory reinnervation as well as use in pediatric patients. » Osseointegration remains a challenge in need of further research given the high risk of infection.
Longitudinal Changes in Volumetric Breast Density in Healthy Women across the Menopausal Transition
Engmann, Natalie J. , Jensen, Matthew R. , Ma, Lin , Brandt, Kathleen R. , Mahmoudzadeh, Amir Pasha , Whaley, Dana H. , Hruska, Carrie B. , Wu, Fang-Fang, Hiatt, Robert A. , Heine, John , Shepherd, John , Miglioretti, Diana L. , Vachon, Celine M. , Mahmoudzadeh, Amir , Hruska, Carrie B , Norman, Aaron D. , Hiatt, Robert A , Pankratz, V. Shane , Miglioretti, Diana L , Scott, Christopher G. , Winham, Stacey J. , Pankratz, V. Shane , Kerlikowske, Karla , Vachon, Celine M.

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | June 11, 2019 | Volume: 28 | Issue: 8 | Pages: 1324-1330

10.1158/1055-9965.epi-18-1375 | PMID 31186265 Get It

Abstract Background: Mammographic breast density declines during menopause. We assessed changes in volumetric breast density across the menopausal transition and factors that influence these changes. Methods: Women without a history of breast cancer, who had full field digital mammograms during both pre- and postmenopausal periods, at least 2 years apart, were sampled from four facilities within the San Francisco Mammography Registry from 2007 to 2013. Dense breast volume (DV) was assessed using Volpara on mammograms across the time period. Annualized change in DV from pre- to postmenopause was estimated using linear mixed models adjusted for covariates and per-woman random effects. Multiplicative interactions were evaluated between premenopausal risk factors and time to determine whether these covariates modified the annualized changes. Results: Among the 2,586 eligible women, 1,802 had one premenopausal and one postmenopausal mammogram, 628 had an additional perimenopausal mammogram, and 156 had two perimenopausal mammograms. Women experienced an annualized decrease in DV [−2.2 cm3 (95% confidence interval, −2.7 to −1.7)] over the menopausal transition. Declines were greater among women with a premenopausal DV above the median (54 cm3) versus below (DV, −3.5 cm3 vs. −1.0 cm3; P < 0.0001). Other breast cancer risk factors, including race, body mass index, family history, alcohol, and postmenopausal hormone therapy, had no effect on change in DV over the menopausal transition. Conclusions: High premenopausal DV was a strong predictor of greater reductions in DV across the menopausal transition. Impact: We found that few factors other than premenopausal density influence changes in DV across the menopausal transition, limiting targeted prevention efforts.